Mohammadreza R. Mohebbi
1 Gheringhap St
Geelong, VIC 3220, Australia
Geelong, VIC 3220, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 229 publications
Inflammation and late-life depressive symptoms.
Journal: medRxiv : the preprint server for health sciences
Published: June 22, 2026
Effect of dispositional optimism and pessimism on the relationship between stressful life events and late-life depression.
Journal: Journal of affective disorders
Published: May 07, 2026
Diet quality and depressive symptoms in older adults, assessing the effect modification by genetic predisposition and low-grade inflammation: a target trial emulation.
Journal: Molecular psychiatry
Published: May 05, 2026
Optimising Nutritional Psychiatry Treatment: Investigating the Mediterranean Diet to Improve Symptoms of Major Depressive Disorder (OPTIMISM): A double-blind sham-controlled randomised feeding trial protocol.
Journal: The British journal of nutrition
Published: May 03, 2026
Associations between metabolic dysfunction-associated steatotic liver disease and physical and mental health-related quality of life in older adults.
Journal: GeroScience
Published: April 28, 2026
An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression (the TIDE trial) protocol.
Journal: BMC psychiatry
Published: March 11, 2026
Psychotropic medication use and bone loss in men: longitudinal study.
Journal: BJPsych open
Published: March 11, 2026
Anti-inflammatory diet and mental health outcomes in an aging population: evidence from a preventive population-based target trial emulation.
Journal: GeroScience
Published: March 06, 2026
Maternal and neonatal cytokine profiles in a twin cohort: evidence from an exploratory pilot study of perinatal immune dysregulation in autism.
Journal: Pediatric research
Published: February 22, 2026
The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) trial: protocol for a 12-week randomised controlled trial of adjunctive Silexan for PTSD.
Journal: BMC complementary medicine and therapies
Published: February 09, 2026
Last Updated: 09/26/2026